FTC Extends Scrutiny Of MDS' $650M Sale To Danaher

Law360, New York (November 3, 2009, 3:26 PM EST) -- Antitrust officials scrutinizing Danaher Corp.’s proposed acquisition of MDS Inc.’s analytical technologies unit have extended their review of the $650 million cash transaction.

On Tuesday, MDS announced that the U.S. Federal Trade Commission sent the life sciences company a second request for information about the slated deal, suggesting regulatory concerns about Danaher’s expansion further into the life sciences instrumentation market.

MDS said the request relates to a global market segment that generates less than $50 million in annual revenue for all sellers, but provided no further...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.